| ADL | Activities of Daily Living |
| ALK | Anaplastic Lymphoma Kinase |
| ARDS | Acute Respiratory Distress Syndrome |
| AORIF | Ablation, Osteoplasty, Reinforcement, and Internal Fixation |
| ASIA | American Spinal Injury Association Impairment Scale |
| AUC | Area Under the Curve |
| BI | Barthel Index |
| BMAs | Bone-Modifying Agents |
| CCI | Charlson Comorbidity Index |
| CI | Confidence Interval |
| CSF | Cerebrospinal Fluid |
| CT | Computed Tomography |
| CTx | Chemotherapy |
| DFS | Disease-Free Survival |
| DMC | Daily Morphine Consumption |
| EBRT | External Beam Radiation Therapy |
| ECOG | Eastern Cooperative Oncology Group |
| ECOG-PS | Eastern Cooperative Oncology Group Performance Status |
| EGFR | Epidermal Growth Factor Receptor |
| EGFR-TKI | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor |
| EORTC | European Organisation for Research and Treatment of Cancer |
| EQ-5D | EuroQol 5-Dimension Questionnaire |
| EQ-5D-3L | EuroQol 5-Dimension 3-Level Questionnaire |
| EQ-5D-5L | EuroQol 5-Dimension 5-Level Questionnaire |
| ESCC | Epidural Spinal Cord Compression |
| FACT-G | Functional Assessment of Cancer Therapy—General |
| FS | Frankel Scale |
| FUSCC | Fudan University Shanghai Cancer Centre |
| HR | Hazard Ratio |
| ICI | Immune Checkpoint Inhibitor |
| IMN | Intramedullary Nailing |
| IMRT | Intensity-Modulated Radiotherapy |
| IQR | Interquartile Range |
| JBI | Joanna Briggs Institute |
| KPS | Karnofsky Performance Status |
| LDCT | Low-Dose Computed Tomography |
| LOS | Length of Stay |
| LTP | Local Tumour Progression |
| MDT | Multidisciplinary Team |
| MeSH | Medical Subject Headings |
| MRI | Magnetic Resonance Imaging |
| MRONJ | Medication-Related Osteonecrosis of the Jaw |
| mRS | Modified Rankin Scale |
| MSCC | Metastatic Spinal Cord Compression |
| MWA | Microwave Ablation |
| NESMS | New England Spinal Metastasis Score |
| NLR | Neutrophil-to-Lymphocyte Ratio |
| NOMS | Neurologic, Oncologic, Mechanical, Systemic Framework |
| NOS | Not Otherwise Specified |
| NRS | Numeric Rating Scale |
| NSCLC | Non-Small Cell Lung Cancer |
| ODI | Oswestry Disability Index |
| OR | Odds Ratio |
| OS | Overall Survival |
| PA | Psychosocial Aspects |
| PC | Pain Characteristics |
| PD-1 | Programmed Cell Death Protein 1 |
| PET | Positron Emission Tomography |
| PET-CT | Positron Emission Tomography–Computed Tomography |
| PFS | Progression-Free Survival |
| PMMA | Polymethylmethacrylate |
| POP | Percutaneous Osteoplasty |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROMIS | Patient-Reported Outcomes Measurement Information System |
| PROSPERO | International Prospective Register of Systematic Reviews |
| PS | Pain Sites |
| PVCR | Posterior Vertebral Column Resection |
| PVP | Percutaneous Vertebroplasty |
| QLQ-BM22 | Quality of Life Questionnaire–Bone Metastases Module 22 |
| QLQ-C30 | Quality of Life Questionnaire–Core 30 |
| QoL | Quality of Life |
| RFA | Radiofrequency Ablation |
| RR | Risk Ratio |
| RT | Radiotherapy |
| SBRT | Stereotactic Body Radiation Therapy |
| SCLC | Small Cell Lung Cancer |
| SEER | Surveillance, Epidemiology, and End Results |
| SINS | Spinal Instability Neoplastic Score |
| SORG | Skeletal Oncology Research Group |
| SREs | Skeletal-Related Events |
| TES | Total En Bloc Spondylectomy |
| TKI | Tyrosine Kinase Inhibitor |
| VAS | Visual Analogue Scale |
| VI | Vitality Index |
| VTE | Venous Thromboembolism |
| WHO | World Health Organization |